Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?

BMJ. 2018 Feb 22;360:k587. doi: 10.1136/bmj.k587.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Drug Approval
  • Drug Resistance, Multiple, Bacterial*
  • Forecasting
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Bacterial Agents